Literature DB >> 26255153

Differential interactions engendered by benzodiazepine and neuroactive steroid combinations on schedule-controlled responding in rats.

Barak W Gunter1, Donna M Platt1, James K Rowlett2.   

Abstract

Benzodiazepines are positive allosteric modulators of the GABAA receptor and are prescribed as anxiolytics, hypnotics, and anticonvulsants. While these drugs clearly have clinical value, their use is associated with unwanted side effects such as sedation and motor impairment. Neuroactive steroids are endogenous modulators of GABAA receptors and recent evidence has shown that combinations of the triazolo-benzodiazepine triazolam and the endogenous neuroactive steroid pregnanolone can produce both supra-additive anxiolytic effects and infra-additive reinforcing effects. In the present study, we investigated these same combinations as well as combinations of two clinically-relevant drugs from different chemical classes, the 1, 4 substituted (7-nitro) benzodiazepine clonazepam and the synthetic neuroactive steroid ganaxolone, in rats trained under a 10-response, fixed ratio (FR) schedule of food reinforcement. All four drugs induced a significant and dose-dependent suppression of food-maintained responding. From the dose-response functions, ED50s (i.e., the doses that engendered 50% of the maximum rate-decreasing effect) were generated for each drug. Dose-response functions for combinations of triazolam/pregnanolone, clonazepam/ganaxolone, triazolam/ganaxolone, and clonazepam/pregnanolone were then determined. Isobolographic analysis of the rate-decreasing effects of these combinations revealed that the potencies of the triazolam/pregnanolone combinations were supra-additive while the clonazepam/ganaxolone combinations were additive or infra-additive in relation to predicted values based on dose-additive effects. Furthermore, mixtures of clonazepam/pregnanolone were supra-additive while triazolam/ganaxolone combinations were additive, infra-additive and supra-additive. These results suggest that the ability of benzodiazepine and neuroactive steroid combinations to attenuate rates of food-maintained responding depends critically on both the constituent drugs and the dose of drug in the mixtures.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Benzodiazepines; Neuroactive steroids; Schedule-controlled responding

Mesh:

Substances:

Year:  2015        PMID: 26255153      PMCID: PMC4567907          DOI: 10.1016/j.pbb.2015.08.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  54 in total

1.  The interaction index: a measure of drug synergism.

Authors:  Ronald J Tallarida
Journal:  Pain       Date:  2002-07       Impact factor: 6.961

2.  Neurosteroids: endogenous allosteric modulators of GABA(A) receptors.

Authors:  Jeremy J Lambert; Michelle A Cooper; Ross D J Simmons; Cameron J Weir; Delia Belelli
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

3.  Acute and chronic effects of the neuroactive steroid pregnanolone on schedule-controlled responding in rhesus monkeys.

Authors:  L R McMahon; C P France
Journal:  Behav Pharmacol       Date:  2002-11       Impact factor: 2.293

4.  Effects of clonazepam and ethosuximide on the responding of pigeons under a fixed-consecutive-number schedule with and without an external discriminative stimulus.

Authors:  M Picker; L Leibold; B Endsley; A Poling
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Anticonflict and reinforcing effects of triazolam + pregnanolone combinations in rhesus monkeys.

Authors:  Bradford D Fischer; James K Rowlett
Journal:  J Pharmacol Exp Ther       Date:  2011-03-16       Impact factor: 4.030

Review 6.  Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse.

Authors:  R R Griffiths; E M Weerts
Journal:  Psychopharmacology (Berl)       Date:  1997-11       Impact factor: 4.530

Review 7.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

Review 8.  A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons.

Authors:  K W Gee; L D McCauley; N C Lan
Journal:  Crit Rev Neurobiol       Date:  1995

9.  Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys.

Authors:  Lance R McMahon; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

10.  Combinations of oxazepam and metyrapone attenuate cocaine and methamphetamine cue reactivity.

Authors:  Courtney M Keller; Elyse M Cornett; Glenn F Guerin; Nicholas E Goeders
Journal:  Drug Alcohol Depend       Date:  2013-07-26       Impact factor: 4.492

View more
  4 in total

1.  Benzodiazepine and neuroactive steroid combinations in rats: anxiolytic-like and discriminative stimulus effects.

Authors:  Barak W Gunter; Sherman A Jones; Ian A Paul; Donna M Platt; James K Rowlett
Journal:  Psychopharmacology (Berl)       Date:  2016-06-29       Impact factor: 4.530

2.  Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats.

Authors:  Norsyifa Harun; Illa Syafiqah Johari; Sharif Mahsufi Mansor; Mohammed Shoaib
Journal:  Psychopharmacology (Berl)       Date:  2019-12-12       Impact factor: 4.530

Review 3.  Isobologram Analysis: A Comprehensive Review of Methodology and Current Research.

Authors:  Ruo-Yue Huang; Linlin Pei; QuanJin Liu; Shiqi Chen; Haibo Dou; Gang Shu; Zhi-Xiang Yuan; Juchun Lin; Guangneng Peng; Wei Zhang; Hualin Fu
Journal:  Front Pharmacol       Date:  2019-10-29       Impact factor: 5.810

4.  Effectiveness of Intratympanic Dexamethasone Injection for Tinnitus Treatment: A Systematic Review and Meta-Analysis.

Authors:  Juyong Chung; Doh Young Lee; Jong Seung Kim; Young Ho Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2022-02-12       Impact factor: 3.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.